David Ball

11PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Oncology and carcinogenesis not elsewhere classifiedRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 09, 2024
A cost-effectiveness analysis of stereotactic ablative radiotherapy versus conventionally fractionated radiotherapy in the management of stage 1 non-small-cell lung cancer: Results from the TROG 09.02 CHISEL study.

Adam Byrne, Richard De Abreu Lourenco, Ramkumar Govindaraj

|Jul 22, 2021
Functional and patient-reported changes in swallowing and voice after combined chemotherapy and radiotherapy for limited-stage small-cell lung cancer.

Jacqui Frowen, Karla Gough, Rhys Hughes

|Jul 12, 2021
Lung cancer treatment patterns and factors relating to systemic therapy use in Australia.

Preston Ngo, David E Goldsbury, Deme Karikios

|May 13, 2020
Does institutional patient accrual volume impact overall survival in patients with inoperable non-small-cell lung cancer receiving radical (chemo)radiation? A secondary analysis of TROG 99.05.

Mun Yee Tan, Richard Fisher, David Ball

|May 10, 2020
Adverse respiratory outcomes following conventional long-course radiotherapy for non-small-cell lung cancer in patients with pre-existing pulmonary fibrosis: A comparative retrospective study.

Clare Bajraszewski, Renee Manser, James Chu

|Nov 23, 2019
Lung organ-at-risk volumes: A survey of practice and the need for a consistent definition in the 4DCT era.

Shalini Vinod, Callie Choong, Philip Vial

Pageof 2

Frequent Collaborators

3 joint publications

Shalini Vinod

1 joint publications

Sarah Everitt

1 joint publications

Wee Loon Ong

1 joint publications

Gerard G Hanna